A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

Not specified

Conditions
CachexiaHIV InfectionsHIV Wasting Syndrome
Interventions
DRUG

Dronabinol

DRUG

Megestrol acetate

Trial Locations (9)

11203

SUNY / Health Sciences Ctr at Brooklyn, Brooklyn

21201

Univ of Maryland at Baltimore / Veterans Adm, Baltimore

60612

Univ of Illinois, Chicago

63110

Washington Univ, St Louis

67214

Univ of Kansas School of Medicine, Wichita

701122699

Tulane Univ Med School, New Orleans

802044507

Denver Public Health Dept, Denver

972109951

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

02908

Univ of Rhode Island / College of Pharmacy, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Roxane Laboratories

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH